瘤驱动因素塑造了人类质瘤中的瘤微环境
bioRxiv : the preprint server for biology
|June 6, 2025
概括
质瘤中的基因组变化塑造了它们的微环境. IDH突变质瘤显示特定的微质细胞,而质细胞瘤具有更多的T细胞和免疫抑制性髓状细胞.
科学领域:
- 神经瘤学神经瘤学
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 质瘤是具有不充分理解瘤微环境的侵袭性脑瘤.
- 瘤基因突变显著影响质瘤的进展,但它们对微环境的影响尚不清楚.
研究的目的:
- 研究基因组变化如何影响质瘤微环境.
- 确定主要驱动突变对空间瘤组织的影响.
主要方法:
- 对93个质瘤样本进行了综合性多核和空间转录核分析.
- 采用了全基因组测序,Hi-C,RNA-seq和Xenium单细胞空间转录学.
- 对IDH突变质瘤和IDH野生型质母细胞瘤进行比较,包括对EGFR放大模式 (ecDNA与线性) 的分析.
主要成果:
- IDH突变质瘤在类似天体细胞的恶性邻居中表现出炎症性微质细胞 (CX3CR1+).
- 质母细胞瘤显示T细胞透和免疫抑制性髓状细胞增加.
- 在EGFR的ecDNA驱动的质母细胞瘤中,表现出类似中细胞的细胞和增加的危险细胞-恶性细胞相互作用,与缺氧和血管增殖有关.
结论:
- 瘤基因放大模式 (线性与ecDNA) 决定了不同的质瘤架构和转录动态.
- 瘤驱动因素显著塑造了质瘤微环境,创造了亚型特定的细胞生态系统.
- 研究结果为开发质瘤向治疗策略提供了洞察力.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer-Critical Genes I: Proto-oncogenes
11.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.2K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K


